Showing results (211-220 of 369) with videos related to
Sort By:
Pageof 37
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2022
Applications of resveratrol in the treatment of gastrointestinal cancerMohammad Roshani, Ameneh Jafari, Amirhossein Loghman, et al.Pharmacological Research|May 18, 2021
Plant-based vaccines and cancer therapy: Where are we now and where are we going?Neda Rahimian, Hamid Reza Miraei, Atefeh Amiri, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2025
Potential role of thymoquinone to treat gastrointestinal cancers: insights into its molecular mechanismsTina Rahjoo, Alireza Motamedzadeh, Felora Ferdosi, et al.European Journal of Medical Research|December 20, 2024
NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targetsAshkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, et al.Current Medicinal Chemistry|December 14, 2019
Resveratrol: A New Potential Therapeutic Agent for Melanoma?Mohamad Hossein Pourhanifeh, Kazem Abbaszadeh-Goudarzi, Mohammad Goodarzi, et al.Heliyon|May 28, 2024
Expression pattern analysis of the long non-coding RNAs (TINCR, RP11-573D15.8, RP11-156E8.1), and their target genes (AKT1, FOXO1 and MAPK3) in patients with HIV infection, and elite controllersJavid Sadri Nahand, Khadijeh Khanaliha, AliReza Khatami, et al.International Journal of Cancer|June 10, 2016
Curcumin: A new candidate for melanoma therapy?Hamed Mirzaei, Gholamreza Naseri, Ramin Rezaee, et al.Journal of Cellular Physiology|June 21, 2018
Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancersLeila Jamali, Roghayeh Tofigh, Sara Tutunchi, et al.BMC Cancer|August 17, 2021
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancerJavid Sadri Nahand, Khadijeh Khanaliha, Hamed Mirzaei, et al.Current Pharmaceutical Design|November 13, 2015
The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatmentSharareh Gholamin, Alireza Pasdar, Mohammad Sadegh Khorrami, et al.Pageof 37